Skip to main content Skip to main navigation menu Skip to site footer
MedNext Journal of Medical and Health Sciences
Review
DOI: 10.54448/mdnt22106%20
Submitted: 22-02-2022
Published: 22-02-2022

Clinical findings and main considerations of the use of bisphosphonate in dental implants: a concise systematic review

UNORP - University Center North Paulista - Sao Jose do Rio Preto, Sao Paulo, Brazil / UNIPOS - Post graduate and continuing education, Sao Jose do Rio Preto, Sao Paulo, Brazil
UNORP - University Center North Paulista - Sao Jose do Rio Preto, Sao Paulo, Brazil / UNIPOS - Post graduate and continuing education, Sao Jose do Rio Preto, Sao Paulo, Brazil
Dental implant Bisphosphonate Osseointegration Osteonecrosis Complications

Abstract

Introduction: In the scenario of dental implant and osseointegration, it is highlighted that the scope of modern dentistry is to restore the patient's normal comfort, function, esthetics, speech, and health. More than one million dental implants are performed each year in the USA. Bisphosphonates (BP) have been the best drug associated with a significant improvement in the quality of life of patients with bone diseases such as Paget's disease, bone metastases, osteogenesis imperfecta, hypercalcemia, and even severe osteoporosis. Objective: Aimed to carry out a concise systematic review of the main considerations regarding the use of bisphosphonate in osseointegration for dental implants. Methods: The present study followed by a systematic review model, following the rules of systematic review – PRISMA. The search strategy was performed in the PubMed, Scielo, Cochrane Library, Web of Science and Scopus, and Google Scholar databases. The Cochrane Instrument was used to assess the risk of bias of the included studies. Results: Bisphosphonate coating of dental implants is a promising tool for surface modification, aiming to improve the osseointegration process and clinical outcome. The biological effects of bisphosphonates are thought to be primarily associated with inhibition of osteoclasts, whereas their effects on osteoblast function are unclear. Thus, surfaces coated with bisphosphonates to stimulate osteoblast differentiation have been investigated by several in vitro studies with contradictory results. Conclusion: Based on results, osteoporosis is a metabolic condition that affects alveolar bone density, but it does not present problems for the installation of osseointegrated implants, as long as there is sufficient bone mass in the region where the tooth will be implanted. Locally administered bisphosphonates induce bone regeneration in periodontal defects and decrease the rate of marginal bone loss after dental implant therapy.

Metrics

Metrics Loading ...

References

  1. de-Freitas NR, Lima LB, de-Moura MB, Veloso-Guedes CC, Simamoto-Júnior PC, de-Magalhães D. Bisphosphonate treatment and dental implants: A systematic review. Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21(5):e644-51. doi: 10.4317/medoral.20920. PMID: 27475681; PMCID: PMC5005105.
  2. Sedghizadeh PP, Sun S, Jones AC, Sodagar E, Cherian P, Chen C, Junka AF, Neighbors JD, McKenna CE, Russell RGG, Ebetino FH. Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications. Bone. 2021 Jun;147:115933. doi: 10.1016/j.bone.2021.115933. Epub 2021 Mar 20. PMID: 33757899; PMCID: PMC8076070.
  3. Jahan S, Kaushik M, Wadhawan A. Comparative Evaluation of Peri-implant Soft and Hard Tissue with and without Application of Bisphosphonate on Implant Surface and Osteotomy Site - A Clinico-radiographic, Cone-beam Computed Tomographic Study. Contemp Clin Dent. 2019 Apr-Jun;10(2):208-213. doi: 10.4103/ccd.ccd_340_18.
  4. Rawal SY, Hilal G. Osteonecrosis and spontaneous exfoliation of dental implants associated with oral bisphosphonate therapy: a case report. Aust Dent J. 2020 Mar;65(1):100-103. doi: 10.1111/adj.12738. Epub 2019 Dec 10.
  5. Touyz LZG, Afrashtehfar KI. Implications of bisphosphonate calcium ion depletion interfering with desmosome epithelial seal in osseointegrated implants and pressure ulcers. Med Hypotheses. 2017 Sep;107:22-25. doi: 10.1016/j.mehy.2017.07.013. Epub 2017 Jul 18.
  6. Pogrel MA, Ruggiero SL. Previously successful dental implants can fail when patients commence anti-resorptive therapy-a case series. Int J Oral Maxillofac Surg. 2018 Feb;47(2):220-222. doi: 10.1016/j.ijom.2017.07.012. Epub 2017 Aug 10.
  7. Chrcanovic BR, Albrektsson T, Wennerberg A. Bisphosphonates and dental implants: A meta-analysis. Quintessence Int. 2016 Apr;47(4):329-42. doi: 10.3290/j.qi.a35523.
  8. Basso FG, Pansani TN, Soares DG, Cardoso LM, Hebling J, de Souza Costa CA. Influence of bisphosphonates on the adherence and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces. Clin Oral Investig. 2018 Mar;22(2):893-900. doi: 10.1007/s00784-017-2167-2. Epub 2017 Jul 8.
  9. Gelazius R, Poskevicius L, Sakavicius D, Grimuta V, Juodzbalys G. Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review. J Oral Maxillofac Res. 2018 Sep 30;9(3):e2. doi: 10.5037/jomr.2018.9302. eCollection 2018 Jul-Sep.
  10. Duarte, P. M.; Nociti Júnior, F. H. Impacto da Deficiência de Estrógeno e suas Terapias sobre o Tecido Ósseo ao Redor de Implantes de Titânio e na Periodontite Induzida em Ratas Ovariectomizadas. Tese (Doutorado) – Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba. Piracicaba, 2004. XVII, 131p.
  11. Kc K, Bhattarai BP, Shrestha S, Shrestha B, Shrestha M. Effect of locally delivered bisphosphonates on alveolar bone: a systematic review and meta-analysis. J Evid Based Dent Pract. 2021 Sep;21(3):101580. doi: 10.1016/j.jebdp.2021.101580. Epub 2021 Apr 29. PMID: 34479678.
  12. Camargo, E. P.; Minosso, M.; Lopes, L. C. Caracterização do Uso de Alendronato de Sódio no Tratamento de Osteoporose por Clínicos da Rede Privada de Duas Cidades do Interior de São Paulo. Rev. Ciênc. Farm. Básica Apl., v.28, n.1, p.77-83, 2007.
  13. Wehner C, Lettner S, Moritz A, Andrukhov O, Rausch-Fan X. Effect of bisphosphonate treatment of titanium surfaces on alkaline phosphatase activity in osteoblasts: a systematic review and meta-analysis. BMC Oral Health. 2020 Apr 25;20(1):125. doi: 10.1186/s12903-020-01089-4.
  14. López-Cedrún JL, Sanromán JF, García A, Peñarrocha M, Feijoo JF, Limeres J, Diz P. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series. Br. j. oral maxillofac. surg. 2012;51(8):874-9.
  15. Hibi H. Iatrogenic risk of osteonecrosis of the jaw? Bone substitutes for dental implants: a warning from Japan. Nagoya J Med Sci. 2020 Feb;82(1):1-3. doi: 10.18999/nagjms.82.1.1.
  16. Ishii, J. H. Osteoporose e os Implantes Dentários. São Paulo, 2009. 24 p.
  17. Ourique S.A.M., Ito A.Y., Suarez O.F. Osteoporose em Implantodontia: O Estado Atual da Questão. Rev. Bras. Implantodontia e Prótese sobre Implantes, 2005: 12(47/48): 237-45.
  18. Ferreira Júnior, C. D; Casado, P. L.; Barboza, E. S. P. Osteonecrose Associada aos Bisfosfonatos na Odontologia. R. Periodontia. v.1, n.4, dez., 2007.
  19. Carvalho, P. S. P. et al. Principais Aspectos da Cirurgia Bucomaxilofacial no Paciente sob Terapia com Bifosfonatos. RFO UPF [online]. 2010, vol.15, n.2, pp. 183-189. ISSN 1413-4012.
  20. Yip JK, Borrell LN, Cho SC, Francisco H, Tarnow DP. Association between oral bisphosphonate use and dental implant failure among middleaged women. J. clin. periodontol. 2012;39:408-14.
  21. Memon S, Weltman RL, Katancik JA. Oral Bisphosphonates: Early Endosseous Dental Implant Success and Crestal Bone Changes. A Retrospective Study. Int. j. oral maxillofac. implants. 2012;279(5):1216-22.
  22. Miranda-Silva W, Montezuma MA, Benites BM, Bruno JS, Fonseca FP, Fregnani ER. Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals. Support Care Cancer. 2020 Nov;28(11):5397-5404. doi: 10.1007/s00520-020-05374-4. Epub 2020 Mar 6. PMID: 32144584.
  23. Goiato MC, Santos DM, Rondon BCS, Moreno A, Baptista GT, Verri FR et al. Care Required When Using Bisphosphonates in Dental Surgical Practice. J. craniofac. surg. 2010; 21(6):1966-70.
  24. Kwon T-G, Lee C-O, Park J-W, Choi S-Y, Rijal G, Shin H-I. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin. oral implants res. 2012; 00:1- 9.
  25. Sampaio FC, Veloso HHP, Barbosa DN. Mecanismos de Ação Dos Bifosfonatos e sua Influência no Prognóstico do Tratamento Endodôntico. Faculdade de odontologia de Porto Alegre, Porto Alegre, 2011, v. 51, n. 1, p. 31-36.

How to Cite

Henk, E., & Manzini, R. (2022). Clinical findings and main considerations of the use of bisphosphonate in dental implants: a concise systematic review. MedNEXT Journal of Medical and Health Sciences, 3(1). https://doi.org/10.54448/mdnt22106